$NKTR

Nektar Therapeutics

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$3.91 β–Ό-0.763%

Last Close

VOLUME

2,650,201

DAY RANGE

3.875 - 4.06

52 WEEK

3.02 - 19.37

Join Discuss about NKTR with like-minded investors

profile
@Atlas #Emporos Research
recently

Closed at even , not dealing with this one , for some time . . .

70 Replies 15 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

Good holding level , holding this one for the final . With additions at 1.5 and 0.75 cents .

114 Replies 11 πŸ‘ 13 πŸ”₯

profile
@Atlas #Emporos Research
recently

i have a feeling NKTR wants to leave me outside of the chase , going in at 3.35 and below again

147 Replies 12 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

NKTR closed at $3.5 , going for $3 or below entry

142 Replies 13 πŸ‘ 15 πŸ”₯

profile
@Atlas #Emporos Research
recently

Pender at 3.35 activated , then the price jumped to 3.53 .

69 Replies 12 πŸ‘ 12 πŸ”₯

profile
@Atlas #Emporos Research
recently

NKTR set to buy purchase at $3.35 .

83 Replies 7 πŸ‘ 6 πŸ”₯

profile
@Atlas #Emporos Research
recently

Closed at $3.57 for even , with 2 cents profit . Market doing bubbles . Going to get in at 3.40 or below .

91 Replies 15 πŸ‘ 7 πŸ”₯

profile
@Atlas #Emporos Research
recently

not yet , NKTR is a mess , stocks dont behave that bad , better practice

53 Replies 8 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

I am actually going to play NKTR long from this position , the game plan does not get better . All entries happen in double purchase style .

48 Replies 12 πŸ‘ 9 πŸ”₯

profile
@Atlas #Emporos Research
recently

Poor NKTR , I guess people are not into caring for their physics , any day now , reality kicks in , and honey comes back .

65 Replies 10 πŸ‘ 6 πŸ”₯

profile
@Atlas #Emporos Research
recently

Penders at 2.00 and $1.00 .

58 Replies 6 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

Closed NKTR at $3.85 , entry was $3.75 . Going to wait for the $3 to $3.50 range since is taking so long , it may go there .

62 Replies 14 πŸ‘ 13 πŸ”₯

profile
@Atlas #Emporos Research
recently

NKTR should experience a 75% return within 5 months , good business .

72 Replies 10 πŸ‘ 12 πŸ”₯

profile
@Atlas #Emporos Research
recently

Entry : 3.75 We will set the break even line to keep 2% every time profit hits 10% . Since we made over 25% of profits on this ticker .

134 Replies 11 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

Closed at 4.50 . Profit 12% .

147 Replies 13 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

Entry : $4 Flat Size : 100% Sorry , busy week had no time to announce .

41 Replies 14 πŸ‘ 6 πŸ”₯

profile
@Atlas #Emporos Research
recently

Closed at 6.15 mid April . For a total ticker profit between 15% to 35% .

40 Replies 7 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

btcusd going above 42k feasibly nktr needs a 1.25 hike to full close

58 Replies 13 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

Entry : 4.0 We rolling this .

110 Replies 7 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

Closed at 5.60 for 30% profit .

97 Replies 9 πŸ‘ 12 πŸ”₯

profile
@Atlas #Emporos Research
recently

nktr , must be playing buying some more

49 Replies 15 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

* NKTR , meant same amount of share investment as in $12 line . That woud nearly 3x shares , good business . Just has to get near $9 and is over a 70% return all together .

104 Replies 15 πŸ‘ 7 πŸ”₯

profile
@Atlas #Emporos Research
recently

Entry : 4.20 Same amount of shares as at $12 line . Already returned 50% .

135 Replies 6 πŸ‘ 9 πŸ”₯

profile
@dros #droscrew
recently

Options with increasing IV: $BEKE $SST $NRZ $MGI $FPAC $BKLN $QYLD Options with decreasing IV: $VIX $WE $FAS $SIG $COUP $FDX $DG $KSS $CS $NKTR $S

95 Replies 11 πŸ‘ 8 πŸ”₯

profile
@dros #droscrew
recently

Options with increasing IV: $CWEB $BEKE $SST $AM $KWEB $CAH $BKLN Options with decreasing IV: $NKTR $DOCU $RIVN $WE $S $ALTO $SIG $ORCL $KSS

74 Replies 13 πŸ‘ 11 πŸ”₯

profile
@Atlas #Emporos Research
recently

there is also more rise in , nktr

132 Replies 11 πŸ‘ 8 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR after providing a 15% return , has not yield a return on a re-entry from $12 , this said , let us not waste more look time , and take a look at it in June of 2022 . Set an email alarm for when price hits 12.50 . From there set a safe stop at 12.20 . Those that are tired of the follow , close the signal at 12.10 for even , if you did not at the advised 11.50 .This stonk is off active list , we have paid a little bit for practice , remember it was stated up to 1 year for a 2x return or way more .

75 Replies 6 πŸ‘ 9 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR is in a new phase , the symbol just experienced its first consistent month after many months of inconsistency . From this bottom line expect an up pitch of at least $3 . That would mark our minimum line around $14 . If this happens from a best line of $10.50 or less , then let it run up , or take 11.50 as a good follow . This is the line that we were expecting at $12 .

149 Replies 8 πŸ‘ 13 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR had projected negative earnings for 2021 , it turned out that for that year , they were all positive earnings , signaling the up to come for the first time . Even if the up does happen , we will put a safe stop right at 12.10 , as soon as it hits 12.50 or so .

77 Replies 7 πŸ‘ 15 πŸ”₯

profile
@Atlas #Emporos Research
recently

Again NKTR passes an 11.50 break even , 50 cents under par for a total gain between two entries of around 16% , not good to waste time , there has been plenty of entries at $10 and below , look for such .

67 Replies 14 πŸ‘ 15 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR should hit 12 within 10 business days , then we will close our last signal , for the 100% win rate on 20 signals during promotion , our forex swing signals improved a lot too , we closed our last 3 entries in less than 48 hours , i am expecting over 60% to close in such manner

58 Replies 15 πŸ‘ 11 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR is our last open signal , we are going to break even at $12 , from the 6% day rise today at 10.50 , expect a 12 hit within 2 weeks , the lucky ones are the ones that got in at 10 and below , 12 was just a good measure

126 Replies 9 πŸ‘ 9 πŸ”₯

profile
@Atlas #Emporos Research
recently

a 25% drop for FB , better to put your money in NKTR , i doubt it will hit 20% drop from 12

140 Replies 10 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

everything still steady , even nktr , is short of 12 by 1 , suppose to break even from new bottom , but the curve looks great graphically , we got played out , good thing we spread the winning

79 Replies 12 πŸ‘ 8 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR is not like forex , btcusd , gold , vix , or similar product . I built a system that relies on business consistency . Is ok to explore stocks , but on first sign of inconsistency we must pull out at even . Consistent products simply guarantee a return a lot faster , not in bank account , but rather in visual repetition , thus passing a better account , good luck .

81 Replies 7 πŸ‘ 10 πŸ”₯

profile
@Atlas #Emporos Research
recently

Close the position at Break Even . The ticker hit $10 , bad sign , there is a new average involved . Get in again near 10 or below .

105 Replies 8 πŸ‘ 8 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR playing within entry line

75 Replies 8 πŸ‘ 6 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR wonderful entry this morning at 11.5 , entry line is 12 and below

62 Replies 9 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

0.5 delta , NKTR

68 Replies 15 πŸ‘ 12 πŸ”₯

profile
@Atlas #Emporos Research
recently

NKTR is hanging to $12 flat for several days , no better signal , the lean is for an up swing before a down

52 Replies 12 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

$NKTR back at entry line , get in on first green week , looks like we will have a better enter than before , this ticker is known for good daily movements in both directions , look for its study as well

130 Replies 12 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

NKTR getting near buy entry line again . . .

107 Replies 15 πŸ‘ 7 πŸ”₯

profile
@Atlas #Emporos Research
recently

nothing new , in btcusd , oil , nktr , i suppose vix is still the same

147 Replies 11 πŸ‘ 6 πŸ”₯

profile
@Atlas #Emporos Research
recently

meant $NKTR

97 Replies 15 πŸ‘ 8 πŸ”₯

profile
@Atlas #Emporos Research
recently

do you have any idea how many people have been waiting for NKTR to go up since Jul-2018 , is at 12.50 , we would be bargaining the entire company

91 Replies 7 πŸ‘ 14 πŸ”₯

profile
@Atlas #Emporos Research
recently

The buy in does not get better then this , try $NKTR .

105 Replies 6 πŸ‘ 13 πŸ”₯

profile
@Atlas #Emporos Research
recently

This is my current active list , no priority order , @EmporosAdmin : VIX BTC Forex Pairs LGVN AMD NKTR FCX

147 Replies 9 πŸ‘ 13 πŸ”₯

profile
@dros #droscrew
recently

5000 $NKTR NOV2021 $19 / $25 call spreads bought 1.00

79 Replies 15 πŸ‘ 12 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, August 5, 2021 Futures Up/Down % Last Dow 55.00 0.16% 34,745 S&P 500 9.25 0.22% 4,404 Nasdaq 33.50 0.22% 15,107 U.S. futures are looking up modestly, rising roughly about 0.2% across the board into one of the heaviest days of corporate earnings of the season, as major averages continue to hold not far off record highs. The S&P 500 index has held the pivotal 4,400 level for over a week now, as overall major averages have moved sideways for two or three weeks now, bolstered by rising on better economic data, earnings results, and an accommodative Fed, which has offset rising Delta variant concerns and fears of further global restrictions to contain the rise in cases and tighter government restrictions in China. Oil prices edge higher after sliding sharply the last 3-days on demand concerns. Bitcoin prices are down about 4% holding just above the $38,000 level while Ethereum slips nearly 4% to 2,600 in the crypto sector. Ahead of tomorrow’s nonfarm payrolls report, investors will get two more labor market data points with the Challenger jobs report at 7:30 and the weekly jobless claims. Euro Stoxx 50 rises 0.5% around best levels for the week. Wednesday’s after-hours big-name earnings were disappointing for the most part, which could weigh on sentiment. Major averages ended the session mixed on Wednesday, following conflicting signals on the economy that showed a hot services sector, but a labor market that continues to struggle to find workers. The Institute for Supply Management survey on Wednesday jumped to a record high of 64.1 in July, but the ADP Employment Report showed private payrolls only rose by 330,000 last month, well shy of the 695,000 estimate ahead of tomorrow’s payrolls. The Dow Jones saw the biggest fall, dragged lower by a decline of more than 6% in Amgen in the wake of its quarterly results, accounting for about 103 points to the downside while energy was the weakest sector on the day, suffering its biggest daily percentage drop since July 19. In Asian markets, The Nikkei Index gained 144 points to 27,728, the Shanghai Index dipped -10 points to 3,466 and the Hang Seng Index declined -221 points (0.84%) to settle at 26,204. In Europe, markets are little changed as the German DAX is up a few points at the 15,700 level, while the FTSE 100 is down a couple of points at 7.120. Market Closing Prices Yesterday The S&P 500 Index slipped -20.49 points, or 0.46%, to 4,402.66 The Dow Jones Industrial Average fell -323.73 points, or 0.92%, to 34,792.67 The Nasdaq Composite edged higher 19.24 points, or 0.13%, to 14,780.53 The Russell 2000 Index declined -27.26 points, or 1.23% to 2,196.32 Events Calendar for Today 7:30 AM ET Challenger Job Layoffs for July 8:30 AM ET Weekly Jobless Claims 8:30 AM EST Continuing Claims 10:30 AM ET Weekly EIA Natural Gas Inventory Data Earnings Calendar: Earnings Before the Open: ABMD, ADNT, AES, AHCO, AKBA, AMRS, ARWR, AVEO, BBGI, BCRX, BDX, BERY, BKI, BLDR, BLL, BV, CAH, CARS, CCOI, CHH, CI, CNP, COMM, CRAI, DDOG, DIN, DLX, DUK, ECOM, EPAM, EPC, EVRG, FOUR, GCP, GNL, GOGO, GOLF, GTN, HBI, HBIO, HII, HL, IDCC, INSM, IRM, IRWD, ITI, K, KPTI, LAMR, LAUR, LNG, LXP, MMS, MPLN, MRNA, MUR, MYE, NINE, NS, NTLA, PCTY, PBH, PBPB, PEI, PENN, PH, PNW, PPL, PRTY, PWR, PZZA, RC, RDUS, REGN, ROLL, SEAS, SSYS, TEN, THS, TRGP, UFS, USPH, VG, VIAC, VST, W, WD, WOW, WRK, XEC, XERS, XTNT, XXII, YETI, ZIXI, ZTS Earnings After the Close: AAOI, AEE, AEL, AIG, AINV, ALRM, ALTR, AMBC, APLE, APPN, ARNA, ASTG, AVLR, AXON, BAND, BECN, BGS, BHF, BIGC, BKD, BL, BRBR, BRKS, BYND, CARG, CDXS, CGNX, CHRS, CHUY, CLNE, CNXN, COLD, CSOD, CVNA, CWK, DBX, DHX, DIOD, EB, ECOR, EGLE, ENTA, ENV, ERII, EXEL, EXPE, FEYE, FLDM, FLS, FND, FOXF, FSR, FTSI, G, GDYN, GEOS, GH, GKOS, GPRO, GRPN, GSBD, HASI, HCAT, HCI, HEAR, HTA, IFF, ILMN, IHRT, IOVA, IRTC, ITT, JCOM, KALA, KAMN, LGF.A, LNT, LOCO, LTHM, MAIN, MDRX, MNST, MP, MSI, MTW, MTZ, NET, NKTR, NVAX, NWSA, NYMT, OLED, OUT, PBYI, PK, PODD, POST, PRA, QDEL, RAMP, RDFN, REZI, RMD, RUN, SFM, SGMO, SHAK, SPCE, SQ, SYNA, TDC, TGH, TMDX, TMST, TRUE, TRUP, TTOO, VLDR, VMEO, VOYA, VV, WSC, Y, YELP, ZEUS, ZG, ZNGA Macro Up/Down Last Nymex 0.37 68.52 Brent 0.26 70.64 Gold 0.40 1,811.75 EUR/USD 0.0005 1.1842 JPY/USD 0.03 109.51 10-Year Note -0.004 1.19% Sector News Breakdown Consumer Boot Barn ($BOOT) Q1 EPS $1.35 vs est. $0.88 in revs $306.3M vs est. $288.9M; same-store sales +78.9% vs 1Q20, +52.3% vs 1Q19; opened 3 new stores in the quarter Costco ($COST) reported total comparable sales for July of +13.8%; July U.S. comparable sales excluding fuel, currencies +8.5% L.F. Beauty ($ELF) 1Q EPS $0.15 vs est. $0.15 on sales $97Mm vs est. $79.3Mm; guides FY adj EPS $0.65-0.68 vs est. $0.67, sees FY sales $356-364Mm vs est. $350.5Mm Etsy Inc. ($ETSY) shares tumble -13% on guidance; 2Q EPS $0.68 vs est. $0.63 on revs $528.9Mm vs est. $524.7Mm, qtrly consolidated GMS $3.0B +13%; guides 3Q revs $500-525Mm vs est. $524.7Mm, sees 3Q GMS $2.9-3.0B Frontdoor Inc. ($FTDR) Q2 EPS $0.76 vs est. $0.63 on revs $462M vs est. $466M, sees Q3 revenue $470M-$480M, lowered FY revenue outlook to $1.6B-$1.62B (est. $1.64B) from $1.63B-$1.65B Jack in the Box ($JACK) Q3 EPS $1.79 vs est. $1.49 on revs $269.5M vs est. $258.5M, same-store sales +10.2%, systemwide sales +10.6%, company-operated same-store sales +9.0%, sees FY21 capex $40M-$45M, FY22 capex $65M-$75M Leslie’s ($LESL) Q3 adj EPS $0.64 vs. est. $0.55; Q3 revs $596.54M vs. est. $570.37M; Q3 comparable sales growth of 23.9%; raises FY21 adjusted EPS view 80c-85c from 75c-80c (est. 77c) and boosts FY21 revs to $1.31B-$1.33B from $1.28B-$1.3B (est. $1.3B); Adjusted EBITDA of $179.3 million compared to $119.8 million in the prior year quarter, an increase of 49.7% MGM Resorts ($MGM) 2Q adj EPS ($0.13) vs est. ($0.30) on net revs $2.3B vs est. $2.28B, MGM China net revs $311Mm, LV Strip net revs $1.0B, regional net revs $856Mm Rent-A-Center ($RCII) 2Q adj EPS $1.63 vs est. $1.35 on revs $1.2B vs est. $1.14B, qtrly comps +16.6% led by e-comm; guides FY revs $4.55-4.67B vs est. $4.56B, sees Rent-A-Center segment revs $2.02-2.06B, sees FY adj EPS $5.90-6.40 vs est. $5.66; announces $250Mm repurchase auth Uber ($UBER) Q2 EPS $0.58 on revs $3.93B vs. est. $3.74B; Q2 gross bookings grew 114% yoy to $21.9 billion, or 104% on a constant currency basis, with Mobility Gross Bookings of $8.6 billion and Delivery Gross Bookings of $12.9 billion; Q2 Adj EBITDA Loss $509M vs. est. loss $324.5M; sees Q3 Adj EBITDA loss below $100M vs. est. loss $95.4M Wynn Resorts (WYNN) 2Q adj EPS ($1.12) vs est. ($1.61) on revs $990.1Mm vs est. $932.5Mm, Wynn Macau revs $184Mm, LV ops revs $355.1Mm ADT Inc. ($ADT) adj EPS ($0.07) vs est. $0.25 on revs $1.304B vs est. $1.28B; Gross recurring monthly revenue (RMR) additions grew 28%; end of period RMR of $352 million increased by 4%; solid customer retention with attrition at 13.3% Driven Brands ($DRVN) 12M share Secondary priced at $29.50 European Wax Center ($EWCZ)6M share IPO priced at $17.00 Weber ($WEBR) 18M (which was cut down from 46.8M) share IPO priced at $14.00 Energy APA Inc. ($APA) Q2 adj EPS $0.70 vs. est. $0.57’ Q2 revs $1.75B vs. est. $1.46B; qtrly adjusted production, which excludes Egypt noncontrolling interest and tax barrels, was 342,000 boe per day; at current strip prices, we expect to generate approximately $1.7B of free cash flow this year Earthstone Energy ($ESTE) files for offering of up to 6.2 mln shares of class a common stock by selling stockholders Marathon Oil ($MRO) Q2 EPS $0.22 vs. est. $0.15; Q2 revs $1.14B vs. est. $1.09B; Q2 oil-equivalent production of 348,000 net boed; raising 2021 full year oil-equivalent production guidance by 5,000 net boed; Q2 oil production of 170,000 net bopd; raised quarterly base dividend by 25% to 5c; raising the midpoint of its 2021 full year U.S. oil-equivalent production guidance by 5,000 net boed Warrior Met Coal ($HCC) 2Q adj EPS $0.25 vs est. ($0.18) on revs $227.4Mm vs est. $128.3Mm; not providing FY guide at this time Whiting Petroleum ($WLL) Q2 adj EPS $3.01 vs. est. $1.97; Q2 revs $352M vs. est. $244.27M; said generated net cash provided by operating activities of $183M and $111M in adjusted free cash flow during the quarter and over $200 million through six months; raises FY21 production view to 88-92 MBOE per day from 82-88 Financials Allstate Corp. ($ALL) Q2 adj EPS $3.79 vs. est. $3.04; Q2 revs $12.65B vs. est. $10.51B; announces new $5B repurchase program; 2Q Book Value Per Shr $86.33; Q2 Catastrophe Loss $952M; Q2 Property-Liability Premiums Earned $10.01B; 2Q Property-Liability Premiums Written $10.32B;2Q Property-Liability Combined Ratio 95.7 Fleetcor ($FLT) Q2 EPS $2.30 vs est. $2.94, adj EPS $3.15, on revs $667.4M vs est. $637.3M; its board increased its share repurchase authorization by$1B; sees Q3 adj EPS $3.35-$3.55 vs est. $3.36, and raised outlook for FY adj EPS to $12.80-$13 (est. $12.61) from $12.32-$12.88 and FY revs to $2.74B-$2.79B (est. $2.68B) from $2.6B-$2.7B Lemonade ($LMND) Q2 EPS loss (-$0.90) vs. est. loss (-$0.89); Q2 revs $28.2M vs. est. $26.8M; customer count increased by 48% to 1,206,172 yoy; premium per customer, defined as in force premium divided by customers, was $246 at the end of the second quarter, up 29% yoy; raises FY21 revenue view to $123M-$125M from $117M-$120M (est. $118.94M); narrows FY21 adjusted EBITDA view to ($173M)-($169M) from ($173M)-($163M) Lincoln National ($LNC) Q2 adj operating EPS $3.17 vs. est. $2.35; Q2 revs $4.85B vs. est. $4.72B; Reports book value per share, including AOCI, of $115.00, up 7%; BVPS, excluding AOCI, of $75.45, up 9% MetLife ($MET) announces new $3B share repurchase authorization; Q2 adj EPS $2.37 vs. est. $1.57; Q2 revs $18.52M vs. est. $15.77B; qtrly premiums, fees & other revenues $11.22 bln vs $10.49 bln; qtrly net investment income $5.28 bln vs $4.09 bln; book value of $75.86 per share at qtr-end, down 4% from $78.65 per share at June 30, 2020 RE/MAX Holdings ($RMAX) 2Q adj EPS $0.63 vs est. $1.31 on revs $77.2Mm vs est. $76.4Mm; guides 3Q revs $86.5-91.5Mm vs est. $79.1Mm; sees FY revs $321-336Mm vs est. $308.7Mm Western Union (WU) Q2 adj EPS $0.48 vs. est. $0.47; Q2 revs $1.3B vs. est. $1.26B; reaffirms FY21 adj EPS view $2.00-$2.10 vs. est. $2.06; reaffirms FY21 revenue growth view mid-to-high single digits; Consumer-to-Consumer (C2C) transactions increased 15% in the quarter, while revenues increased 15% on a reported basis, or 12% constant currency. Robinhood ($HOOD) filed with the SEC a prospectus related to the offer and sale from time to time of up to 97,876,033 shares of Class A common stock of Robinhood Markets, Inc. by certain selling stockholders

142 Replies 8 πŸ‘ 13 πŸ”₯

Key Metrics

Market Cap

726.47 M

Beta

0

Avg. Volume

3.97 M

Shares Outstanding

186.27 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.

CEO: Howard Robin

Website:

HQ: 455 Mission Bay Blvd S San Francisco, 94158-2158 California

Related News